Medasense Biometrics

Noninvasive Pain-monitoring Solutions

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in June 2008 by Galit Zuckerman, Medasense Biometrics operates with 11–50 employees. The company has raised $33.5M across 5 funding rounds from 9 investors. In January 2025, Medasense Biometrics secured funding from the BIRD Foundation.

Business overview

Medasense Biometrics develops noninvasive pain-monitoring solutions for clinicians to optimize and personalize pain control and avoid overmedication. Its core product, the PMD-200 with its NOL index, is an AI-powered platform that objectively monitors and quantifies a patient's pain response using a proprietary noninvasive sensor system. The technology is primarily used in operating rooms and critical care settings where patients cannot communicate, serving the healthcare industry within the Digital Health and Medical Technologies sectors.

Strategic signal

In February 2023, the FDA authorized the marketing of Medasense's NOL technology to measure pain in anesthetized patients. This regulatory approval is a significant validation of the technology's efficacy and safety, opening up substantial market opportunities in the United States and signaling strong potential for broader adoption and commercial growth.

Log in to access full profile

Company Intelligence Q&A

What is Medasense Biometrics' primary product?
Medasense Biometrics' flagship product is the PMD-200, which incorporates the NOL index. This platform uses artificial intelligence and a proprietary noninvasive sensor system to objectively monitor and quantify a patient's pain response.
When was Medasense Biometrics founded?
Medasense Biometrics was founded in June 2008.
Which investors participated in Medasense Biometrics' September 2020 funding round?
In September 2020, Medasense Biometrics received funding from Sabadell Asabys VC and OTV.
What was a key regulatory milestone for Medasense Biometrics?
In February 2023, the FDA authorized the marketing of Medasense's NOL technology for measuring pain in anesthetized patients.
Which investors participated in Medasense Biometrics' November 2015 funding round?
In November 2015, Medasense Biometrics received funding from OTV and Baxter Ventures.
Log in to access full profile